These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21904315)

  • 1. Shaping the future of safer innovative drugs in Europe.
    Mestres J; Bryant SD; Zamora I; Gasteiger J
    Nat Biotechnol; 2011 Sep; 29(9):789-90. PubMed ID: 21904315
    [No Abstract]   [Full Text] [Related]  

  • 2. Members need only apply.
    Nat Biotechnol; 2011 Jul; 29(7):551. PubMed ID: 21747362
    [No Abstract]   [Full Text] [Related]  

  • 3. Impossible fixes.
    Nat Biotechnol; 2010 Feb; 28(2):103. PubMed ID: 20139925
    [No Abstract]   [Full Text] [Related]  

  • 4. How the EU can fund your company.
    Gilbert N
    Nat Biotechnol; 2007 Jan; 25(1):21-4. PubMed ID: 17294566
    [No Abstract]   [Full Text] [Related]  

  • 5. Europe joins UK open-access bid.
    Van Noorden R
    Nature; 2012 Jul; 487(7407):285. PubMed ID: 22810672
    [No Abstract]   [Full Text] [Related]  

  • 6. European competition.
    Nat Mater; 2006 Nov; 5(11):839. PubMed ID: 17077838
    [No Abstract]   [Full Text] [Related]  

  • 7. Europe provides 172m euro for research into innovative medicines.
    Watson R
    BMJ; 2011 Mar; 342():d1577. PubMed ID: 21393337
    [No Abstract]   [Full Text] [Related]  

  • 8. [What is the fair price of innovative therapy?].
    Fischer A; Dewatripont M; Goldman M
    Med Sci (Paris); 2020 Apr; 36(4):389-393. PubMed ID: 32356716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Establishing ophthalmology in the research framework programs of the European Union].
    Scholl HP; Wheeler-Schilling TH; Zrenner E; Holz FG
    Ophthalmologe; 2006 Feb; 103(2):91-9. PubMed ID: 16437232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spat over IMI funding and intellectual property.
    Sinha G
    Nat Biotechnol; 2011 Jun; 29(6):473. PubMed ID: 21654659
    [No Abstract]   [Full Text] [Related]  

  • 11. Report: EuroBioFund first annual forum in Helsinki.
    Biotechnol J; 2007 Apr; 2(4):406-7. PubMed ID: 17407205
    [No Abstract]   [Full Text] [Related]  

  • 12. [France in the European and International research landscape].
    Julkowska D
    Med Sci (Paris); 2018 May; 34 Hors série n°1():55-57. PubMed ID: 29911567
    [No Abstract]   [Full Text] [Related]  

  • 13. In vogue with venture.
    Patou G
    Nat Biotechnol; 2011 Nov; 29(11):967-9. PubMed ID: 22175076
    [No Abstract]   [Full Text] [Related]  

  • 14. [France in the European cooperation for the technological evaluation of health products].
    Meyer F
    Med Sci (Paris); 2018 May; 34 Hors série n°1():57-59. PubMed ID: 29911568
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotech firms jump on SARS bandwagon.
    Basu P
    Nat Biotechnol; 2003 Jul; 21(7):720. PubMed ID: 12833076
    [No Abstract]   [Full Text] [Related]  

  • 16. Open-minded to open innovation and precompetitive collaboration.
    Wagner JA
    Clin Pharmacol Ther; 2010 May; 87(5):511-5. PubMed ID: 20407451
    [No Abstract]   [Full Text] [Related]  

  • 17. EC grant helps counter Chechen refugee-camp closures.
    Parfitt T
    Lancet; 2004 Jan; 363(9403):136. PubMed ID: 14733195
    [No Abstract]   [Full Text] [Related]  

  • 18. Eurofile. Private-public drive to cut delays in drug development.
    Mundell I
    Eur J Cancer; 2008 Jan; 44(2):169. PubMed ID: 18335586
    [No Abstract]   [Full Text] [Related]  

  • 19. Europe (against) for cancer.
    Lancet; 1990 Oct; 336(8722):1036. PubMed ID: 1977023
    [No Abstract]   [Full Text] [Related]  

  • 20. 2 billion euro IMI launched with European pharma.
    Hodgson J
    Nat Biotechnol; 2008 Jul; 26(7):717-8. PubMed ID: 18612274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.